Arizona SB 1749: prescription drugs; upper payment limit.

Status: Senate Second Reading (as of 2021-02-04)

State: Arizona · Session: 55th-1st-regular · Bill: SB 1749

Subjects: AFFORDABILITY, AFFORDABILITY BOARD, AFFORDABILITY REVIEW, ANNUAL REPORT, APPEALS, APPLICABILITY, APPOINTMENT, APPROPRIATING MONIES, APPROPRIATION, ASSESSMENTS, COMPENSATION, CONFLICT OF INTEREST, COUNCIL MEMBERS, DEFINITION, DEFINITIONS, DRUG COST, EFFECTIVE DATE, HEALTH AND HUMAN SERVICES COMMITTEES, HEALTH CARE ADVOCACY COALITION, IDENTIFICATION, INITIAL TERMS, LIMITS, MANUFACTURER, MEMBERS, MEMBERSHIP, MONIES, POWERS AND DUTIES, PRESCRIPTION DRUG AFFORDABILITY BOARD, PRESCRIPTION DRUG AFFORDABILITY FUND, PRESCRIPTION DRUG AFFORDABILITY STAKEHOLDER COUNCIL, PRESCRIPTION DRUG PRODUCTS, PRESCRIPTION DRUGS, PROHIBITED, PUBLIC HEALTH AND SAFETY - TITLE 36, PURPOSE, REMEDIES, RULES, SEVERABILITY, STATE GENERAL FUND, STUDY, UPPER PAYMENT LIMIT, UPPER-PAYMENT

Sponsors: Tony Navarrete, Jamescita Peshlakai, Juan Mendez, Lela Alston, Lisa Otondo, Lupe Contreras, Rebecca Rios

View Arizona SB 1749 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.